These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Open innovation and licensing in the pharmaceutical industry]. Yamasaki M. Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):28-31. PubMed ID: 23842225 [No Abstract] [Full Text] [Related]
3. [Change the world through business partnering - commercialization of biotechnology and open-innovation]. Tsukamoto Y. Nihon Yakurigaku Zasshi; 2013 May; 141(5):268-74. PubMed ID: 23665558 [No Abstract] [Full Text] [Related]
10. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia]. Iida K, Yano T, Ikemori M, Ishida T, Nishimura N. Yakugaku Zasshi; 2021 Jun 01; 141(6):877-886. PubMed ID: 33642438 [Abstract] [Full Text] [Related]
11. Q&A: Bernard Munos. Bender E. Nature; 2016 May 12; 533(7602):S59. PubMed ID: 27167392 [No Abstract] [Full Text] [Related]
16. Drug discovery: new models for industry-academic partnerships. Tralau-Stewart CJ, Wyatt CA, Kleyn DE, Ayad A. Drug Discov Today; 2009 Jan 07; 14(1-2):95-101. PubMed ID: 18992364 [Abstract] [Full Text] [Related]
19. The road ahead for large pharma: long-term science and innovation. Lundberg JM, Reilly C. Drug Discov Today; 2009 May 07; 14(9-10):439-41. PubMed ID: 19429501 [No Abstract] [Full Text] [Related]
20. Drug development: Time for teamwork. May M. Nature; 2014 May 01; 509(7498):S4-5. PubMed ID: 24784427 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]